Cargando…

Identifying and reducing inappropriate aspirin use in primary care

OBJECTIVE: Recent studies have called into question the safety of aspirin use for the primary prevention of atherosclerotic cardiovascular disease, particularly in older adults. Therefore, the objectives of this study were to (1) develop a systematic approach to identifying patients aged 70 and olde...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooker, Christa, Compton, Rebekah, Babineau, Terri, Normeshie, Cornelius Afetorli, Li, Li, Blackstone, Sarah Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632878/
https://www.ncbi.nlm.nih.gov/pubmed/37931985
http://dx.doi.org/10.1136/bmjoq-2023-002457
_version_ 1785132664555044864
author Brooker, Christa
Compton, Rebekah
Babineau, Terri
Normeshie, Cornelius Afetorli
Li, Li
Blackstone, Sarah Rachel
author_facet Brooker, Christa
Compton, Rebekah
Babineau, Terri
Normeshie, Cornelius Afetorli
Li, Li
Blackstone, Sarah Rachel
author_sort Brooker, Christa
collection PubMed
description OBJECTIVE: Recent studies have called into question the safety of aspirin use for the primary prevention of atherosclerotic cardiovascular disease, particularly in older adults. Therefore, the objectives of this study were to (1) develop a systematic approach to identifying patients aged 70 and older taking aspirin for primary prevention, (2) provide patient and provider education about updated literature and recommendations regarding aspirin safety and (3) evaluate the impact of this intervention on aspirin de-prescribing. DESIGN: This was a quality improvement intervention with prospective, longitudinal follow-up. SETTING: This study was conducted in two family medicine practices within an academic medical centre. PARTICIPANTS: Patients aged 70 years and older with aspirin listed on the current medication list. METHODS: This is an electronic medical record-based chart review and educational intervention based on shared decision-making to reduce inappropriate aspirin use in primary practice. A chart review process was developed to identify the clinical indication for aspirin use. Patients taking aspirin for primary prevention were flagged for the primary care providers to review. Multilevel logistic regression models assessed factors affecting aspirin de-prescribing and longitudinal trend. RESULTS: Of 361 patients aged 70 years or older, 145 (40%) were taking aspirin for primary prevention of atherosclerotic cardiovascular disease. After 9 months, aspirin was deprescribed in 42 (29%) of these patients. Patients seen by their providers during the study period had lower odds of having aspirin on their medication list (OR=0.87, 95% CI: 0.81, 0.94) as compared with patients taking aspirin who were not seen by their healthcare provider. CONCLUSION: This is the first study to develop and implement a method of identifying potentially inappropriate aspirin use based on recent clinical evidence highlighting the risk of aspirin use for primary prevention in older adults. Future initiatives can leverage existing electronic medical record platforms to efficiently identify patients and expand these efforts to larger patient populations.
format Online
Article
Text
id pubmed-10632878
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-106328782023-11-10 Identifying and reducing inappropriate aspirin use in primary care Brooker, Christa Compton, Rebekah Babineau, Terri Normeshie, Cornelius Afetorli Li, Li Blackstone, Sarah Rachel BMJ Open Qual Quality Improvement Report OBJECTIVE: Recent studies have called into question the safety of aspirin use for the primary prevention of atherosclerotic cardiovascular disease, particularly in older adults. Therefore, the objectives of this study were to (1) develop a systematic approach to identifying patients aged 70 and older taking aspirin for primary prevention, (2) provide patient and provider education about updated literature and recommendations regarding aspirin safety and (3) evaluate the impact of this intervention on aspirin de-prescribing. DESIGN: This was a quality improvement intervention with prospective, longitudinal follow-up. SETTING: This study was conducted in two family medicine practices within an academic medical centre. PARTICIPANTS: Patients aged 70 years and older with aspirin listed on the current medication list. METHODS: This is an electronic medical record-based chart review and educational intervention based on shared decision-making to reduce inappropriate aspirin use in primary practice. A chart review process was developed to identify the clinical indication for aspirin use. Patients taking aspirin for primary prevention were flagged for the primary care providers to review. Multilevel logistic regression models assessed factors affecting aspirin de-prescribing and longitudinal trend. RESULTS: Of 361 patients aged 70 years or older, 145 (40%) were taking aspirin for primary prevention of atherosclerotic cardiovascular disease. After 9 months, aspirin was deprescribed in 42 (29%) of these patients. Patients seen by their providers during the study period had lower odds of having aspirin on their medication list (OR=0.87, 95% CI: 0.81, 0.94) as compared with patients taking aspirin who were not seen by their healthcare provider. CONCLUSION: This is the first study to develop and implement a method of identifying potentially inappropriate aspirin use based on recent clinical evidence highlighting the risk of aspirin use for primary prevention in older adults. Future initiatives can leverage existing electronic medical record platforms to efficiently identify patients and expand these efforts to larger patient populations. BMJ Publishing Group 2023-11-06 /pmc/articles/PMC10632878/ /pubmed/37931985 http://dx.doi.org/10.1136/bmjoq-2023-002457 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Quality Improvement Report
Brooker, Christa
Compton, Rebekah
Babineau, Terri
Normeshie, Cornelius Afetorli
Li, Li
Blackstone, Sarah Rachel
Identifying and reducing inappropriate aspirin use in primary care
title Identifying and reducing inappropriate aspirin use in primary care
title_full Identifying and reducing inappropriate aspirin use in primary care
title_fullStr Identifying and reducing inappropriate aspirin use in primary care
title_full_unstemmed Identifying and reducing inappropriate aspirin use in primary care
title_short Identifying and reducing inappropriate aspirin use in primary care
title_sort identifying and reducing inappropriate aspirin use in primary care
topic Quality Improvement Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632878/
https://www.ncbi.nlm.nih.gov/pubmed/37931985
http://dx.doi.org/10.1136/bmjoq-2023-002457
work_keys_str_mv AT brookerchrista identifyingandreducinginappropriateaspirinuseinprimarycare
AT comptonrebekah identifyingandreducinginappropriateaspirinuseinprimarycare
AT babineauterri identifyingandreducinginappropriateaspirinuseinprimarycare
AT normeshiecorneliusafetorli identifyingandreducinginappropriateaspirinuseinprimarycare
AT lili identifyingandreducinginappropriateaspirinuseinprimarycare
AT blackstonesarahrachel identifyingandreducinginappropriateaspirinuseinprimarycare